JP2012211908A5 - - Google Patents

Download PDF

Info

Publication number
JP2012211908A5
JP2012211908A5 JP2012121097A JP2012121097A JP2012211908A5 JP 2012211908 A5 JP2012211908 A5 JP 2012211908A5 JP 2012121097 A JP2012121097 A JP 2012121097A JP 2012121097 A JP2012121097 A JP 2012121097A JP 2012211908 A5 JP2012211908 A5 JP 2012211908A5
Authority
JP
Japan
Prior art keywords
content
phosphoethanolamine
blood
value
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012121097A
Other languages
English (en)
Japanese (ja)
Other versions
JP5372213B2 (ja
JP2012211908A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012121097A priority Critical patent/JP5372213B2/ja
Priority claimed from JP2012121097A external-priority patent/JP5372213B2/ja
Publication of JP2012211908A publication Critical patent/JP2012211908A/ja
Publication of JP2012211908A5 publication Critical patent/JP2012211908A5/ja
Application granted granted Critical
Publication of JP5372213B2 publication Critical patent/JP5372213B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012121097A 2009-08-12 2012-05-28 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体 Active JP5372213B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012121097A JP5372213B2 (ja) 2009-08-12 2012-05-28 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2009187521 2009-08-12
JP2009187521 2009-08-12
JP2009291029 2009-12-22
JP2009291029 2009-12-22
JP2012121097A JP5372213B2 (ja) 2009-08-12 2012-05-28 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011526785A Division JPWO2011019072A1 (ja) 2009-08-12 2010-08-12 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013191911A Division JP5859502B2 (ja) 2009-08-12 2013-09-17 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体

Publications (3)

Publication Number Publication Date
JP2012211908A JP2012211908A (ja) 2012-11-01
JP2012211908A5 true JP2012211908A5 (enExample) 2012-12-13
JP5372213B2 JP5372213B2 (ja) 2013-12-18

Family

ID=43586246

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011526785A Pending JPWO2011019072A1 (ja) 2009-08-12 2010-08-12 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体
JP2012121097A Active JP5372213B2 (ja) 2009-08-12 2012-05-28 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体
JP2013191911A Active JP5859502B2 (ja) 2009-08-12 2013-09-17 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011526785A Pending JPWO2011019072A1 (ja) 2009-08-12 2010-08-12 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013191911A Active JP5859502B2 (ja) 2009-08-12 2013-09-17 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体

Country Status (6)

Country Link
US (2) US8951739B2 (enExample)
EP (1) EP2466312B1 (enExample)
JP (3) JPWO2011019072A1 (enExample)
CN (2) CN104777314B (enExample)
DK (1) DK2466312T3 (enExample)
WO (1) WO2011019072A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5731860B2 (ja) * 2011-03-11 2015-06-10 テルモ株式会社 腹膜組織の傷害検出方法
EP2778233B1 (en) * 2011-11-10 2017-01-11 Human Metabolome Technologies, Inc. Method for measuring ethanolamine phosphate
EP3228313B1 (en) 2013-01-22 2019-09-11 Vistagen Therapeutics, Inc. Dosage forms and therapeutic uses of l-4-chlorokynurenine
JP6211283B2 (ja) * 2013-03-29 2017-10-11 ヒューマン・メタボローム・テクノロジーズ株式会社 脳症の検出方法
CN103630678A (zh) * 2013-03-29 2014-03-12 中国科学院城市环境研究所 男性不育的生物标志物及其应用
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
HK1223174A1 (zh) * 2013-05-23 2017-07-21 Iphenotype Llc 表型整合社交搜索数据库及方法
US20150056605A1 (en) * 2013-08-21 2015-02-26 Purdue Research Foundation Identification of blood based metabolite biomarkers of pancreatic cancer
CN103529159B (zh) * 2013-10-18 2015-05-13 哈尔滨医科大学 一种血液非靶标代谢组学研究样品的前处理方法
WO2016047677A1 (ja) * 2014-09-26 2016-03-31 ヒューマン・メタボローム・テクノロジーズ株式会社 うつ病治療薬の選択肢を予測する方法
KR101604074B1 (ko) * 2015-05-14 2016-03-17 한국과학기술원 대사체 프로파일링을 이용한 정신질환의 진단 또는 진행성 예측 방법 및 바이오마커
CN105177117A (zh) * 2015-07-03 2015-12-23 张理义 重症抑郁障碍生物标记物、筛选方法及试剂盒
CN104991010B (zh) * 2015-07-29 2017-10-13 中国药科大学 一种区分乳腺癌亚型生物标志物的组合物
EP3677914A1 (en) * 2015-11-12 2020-07-08 Kyushu University National University Corporation Biomarker for diagnosing depression and use of biomarker
CN105445408B (zh) * 2016-01-25 2018-06-12 齐炼文 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物
CN105486778B (zh) * 2016-01-25 2017-11-03 齐炼文 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物
CA3026049C (en) * 2016-06-02 2024-04-09 Metabolon, Inc. Mass spectrometry method for detection and quantitation of metabolites
MX2019002918A (es) * 2016-09-16 2019-07-18 Dyax Corp Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activacion por contacto.
WO2018117064A1 (ja) * 2016-12-21 2018-06-28 国立大学法人徳島大学 うつ状態を呈する疾患を検査する方法
US11869633B2 (en) * 2017-12-15 2024-01-09 The Board Of Trustees Of The University Of Illinois Analytics and machine learning framework for actionable intelligence from clinical and omics data
US11815515B2 (en) * 2018-01-17 2023-11-14 University Of Southampton Methods to predict risk of and to stratify sarcopenia and NAD deficiency
CN112689755A (zh) * 2018-09-11 2021-04-20 梅塔博隆股份有限公司 用于检测和定量微生物区系相关代谢物的质谱测定法
JPWO2020122231A1 (ja) 2018-12-13 2021-10-21 キッコーマン株式会社 エタノールアミンリン酸の定量方法、定量用のオキシドレダクターゼ、定量用組成物、定量用キット及び定量用センサー
WO2020185580A1 (en) * 2019-03-13 2020-09-17 Duke University Methods and compositions for diagnosing depression
CN110286191A (zh) * 2019-06-27 2019-09-27 山西大学 一种生物样品中代谢标志物检测方法及应用
JP7607036B2 (ja) * 2019-10-11 2024-12-26 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 気分障害の改善のためのバイオマーカーとしての２－メチルブチレート
GB201916185D0 (en) * 2019-11-07 2019-12-25 Randox Laboratories Ltd Biomarker of drug-induced cellular toxicity and depression
US20210386704A1 (en) * 2020-06-15 2021-12-16 Universitätsspital Basel Mdma response prediction
EP4170041A4 (en) 2020-06-17 2024-07-17 Kikkoman Corporation METHOD FOR QUANTIFICATION OF ETHANOLAMINE PHOSPHATE, OXIDE REDUCTASE FOR QUANTIFICATION, QUANTIFICATION COMPOSITION, QUANTIFICATION KIT, SENSOR CHIP AND SENSOR
CN111693624B (zh) * 2020-06-22 2021-07-09 南京市中医院 一种与儿童多发性抽动症诊断相关的血浆代谢标志物在制备儿童多发性抽动症诊断试剂盒中的应用
CN112630311B (zh) * 2020-07-09 2023-07-18 深圳云合医药科技合伙企业(有限合伙) 用于检测情感障碍的代谢标记物和试剂盒及使用方法
EP4237848A4 (en) * 2020-10-30 2024-09-25 The Regents of The University of California COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH A HISTORY OF EARLY LIFE ADVERSE
CN114544826B (zh) * 2020-11-24 2023-12-08 重庆医科大学 检测血浆中组氨酸的试剂在制备抑郁症检测试剂盒中的用途
CN114624345B (zh) * 2020-12-10 2023-06-06 中国科学院大连化学物理研究所 一种联合生物标志物及其应用
US11854684B2 (en) * 2020-12-29 2023-12-26 Kpn Innovations, Llc. Methods and systems for nourishment refinement using psychiatric markers
WO2023041681A1 (en) * 2021-09-17 2023-03-23 Société des Produits Nestlé S.A. Method for detecting and/or quantifying mood disorder and/or improvements of the mood disorder status using butyrate as biomarker and improved methods and compositions thereof
CN117836631A (zh) * 2021-09-28 2024-04-05 雀巢产品有限公司 使用葫芦巴碱作为生物标志物检测和/或量化心境障碍和/或心境障碍状态改善的方法及其改进的方法和组合物
US12100484B2 (en) 2021-11-01 2024-09-24 Matterworks Inc Methods and compositions for analyte quantification
US20230137741A1 (en) 2021-11-01 2023-05-04 Matterworks Inc Methods and compositions for analyte quantification
JP2023069050A (ja) * 2021-11-04 2023-05-18 国立大学法人九州大学 ひきこもりのバイオマーカー、ひきこもり識別支援方法
CN114176581A (zh) * 2021-12-06 2022-03-15 重庆邮电大学 基于体液中l-酪氨酸含量的抑郁情绪检测装置
CN116429952B (zh) * 2023-03-27 2024-02-02 深圳市第二人民医院(深圳市转化医学研究院) 一种抑郁症标志物及其在抑郁症诊断中的应用、评估装置
CN116990498B (zh) * 2023-09-28 2024-08-09 山东大学齐鲁医院 血浆色氨酸代谢物在儿童偏头痛诊断中的应用
CN117590005A (zh) * 2024-01-15 2024-02-23 中国疾病预防控制中心环境与健康相关产品安全所 空气污染致抑郁的代谢标志物组合及其筛选方法和应用
WO2025163640A1 (en) * 2024-01-31 2025-08-07 Sheba Impact Ltd. Ai based clinical decision support system (cdss) for mental health
CN118566488A (zh) * 2024-04-10 2024-08-30 合肥歆智医疗器械有限公司 抑郁症检测用试剂组合、制造方法、检测系统及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314144A (en) * 1996-02-02 1999-04-29 Smithkline Beecham Corp Computerised identification of at risk patients diagnosed with depression
GB9826899D0 (en) * 1998-12-08 1999-01-27 Knoll Ag Methods to treat depression and other psychiatric disorders and assays for compounds
WO2004080312A1 (ja) 2003-03-14 2004-09-23 Seizaburo Arita うつ病の診断方法
EP2146209B1 (en) 2005-04-06 2011-11-16 University of Antwerp Neurodegenerative markers for Alzheimer's disease
JP2007024822A (ja) 2005-07-21 2007-02-01 Aska Pharmaceutical Co Ltd 男性の更年期又はうつ病の鑑別方法
GB0524609D0 (en) * 2005-12-02 2006-01-11 Univ Cambridge Tech Methods of monitoring and diagnosing psychotic disorders and of identifying biomarkers for psychotic disorders
US7606622B2 (en) * 2006-01-24 2009-10-20 Cardiac Pacemakers, Inc. Method and device for detecting and treating depression
US20080281531A1 (en) 2007-03-15 2008-11-13 Kazuhito Rokutan Method for Diagnosing Depression
CN101796408B (zh) * 2007-06-29 2014-05-07 奎斯特诊断投资公司 用液相层析-质谱法分析体液内的氨基酸
CN101338337B (zh) * 2007-07-04 2011-11-02 北京华安佛医药研究中心有限公司 多态性位点基因型预测抑郁症及药效的用途、方法和试剂盒
JP2009092550A (ja) 2007-10-10 2009-04-30 Japan Health Science Foundation うつ病またはうつ状態の同定方法
JP2009187521A (ja) 2008-01-08 2009-08-20 Yaskawa Electric Corp 位置指令作成方法及び位置指令作成装置
JP2009291029A (ja) 2008-05-30 2009-12-10 Yazaki Corp コルゲートチューブ配索部材

Similar Documents

Publication Publication Date Title
JP2012211908A5 (enExample)
Jin et al. Acoustic analysis of snoring in the diagnosis of obstructive sleep apnea syndrome: a call for more rigorous studies
BR112015003046A2 (pt) sistema de neurofeedback, processador de sinal para determinação de uma característica do sinal do sinal do biofeedback medido, método para provisão de um usuário com o neurofeedback e programa de computador.
MX373784B (es) Determinacion de un indicador de riesgo de salud
JP2014516593A5 (enExample)
MX2020005042A (es) Sistema para monitorizar pacientes que padecen de enfermedad respiratoria que comprende un dispositivo medico portatil y metodo basado en el uso de este sistema.
JP2010540127A5 (enExample)
CN103961113A (zh) 用于基于用户的行为测量压力的设备和方法
GB2526503A (en) Circulation monitoring system
Justine et al. Health-related quality of life, lung function and dyspnea rating in COPD patients
JP2016516191A5 (enExample)
JP2017505897A5 (enExample)
Darnall et al. Application of machine learning and numerical analysis to classify tremor in patients affected with essential tremor or Parkinson's disease
JP2016506278A5 (enExample)
JP2016116746A5 (enExample)
BR112012030051A2 (pt) índice de saúde oral
Padwal et al. Comparability of two commonly used automated office blood pressure devices in the severely obese
De Luca-Monasterios et al. Effect of chewing gum on halitosis
JP2015049050A5 (enExample)
JP2015077387A5 (enExample)
JP2018181352A5 (enExample)
FI20135852A7 (fi) Laite ja järjestelmä veren glukoosipitoisuuden mittaamiseksi ja esittämiseksi
Boes et al. C37 COPD: WHAT IS NEW IN IMAGING?: Parametric Response Maps As A CT Biomarker For Monitoring The Temporal Evolution Of COPD
Nofuentes et al. Determining sample size to evaluate and compare the accuracy of binary diagnostic tests in the presence of partial disease verification
Morris et al. How Smart Are These Socks? Using Smart Socks To Detect Slow Walking Speeds During Overground Walking In Healthy Adults